RISK ASSESSMENT OF CHANGE OVER IN PRODUCTION FACILITIES OF MRNA AND VLP BASED VACCINES AT FORMULATION AND FILLING STAGES OF FINAL PRODUCT,
In the context of efficiency in terms of investment and accelerating timeline for providing products to the market, several strategies that can be implemented by biopharmaceutical industry in Indonesia include the use of multi-product production facilities. However, the risk of cross-contamina...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/78370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |